FIELD: medicine.
SUBSTANCE: leuko-platelet mass, isolated from anticoagulated blood, contains platelets and leukocytes in their individual concentration, exceeding their concentration in blood, at least, 2 times. Medication consists of described above leuko-platelet mass and platelet activator. Treatment by impact of leuko-platelet mass and based on it medication lies in increase of content of factors of new vessel growth and factors which contribute to tissue regeneration.
EFFECT: leuko-platelet mass and based on it medication make it possible to reduce term of treatment and increase its quality.
14 cl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF OBTAINING AUTOLOGIC PLATELET GEL | 2010 |
|
RU2428995C1 |
| METHOD OF PRODUCING PLATELET-RICH BLOOD PLASMA FOR TREATMENT OF MACULAR RETINAL HOLES | 2022 |
|
RU2805814C1 |
| METHOD OF TREATING CORNEAL DEFECTS VIA AN AUTOLOGOUS THROMBOFIBRIN CLOT | 2019 |
|
RU2699206C1 |
| DERIVED FROM HUMAN THROMBOCYTE LYSATE, EXTRACELLULAR VESICLES FOR USE IN MEDICINE | 2017 |
|
RU2735139C2 |
| COMBINATION FOR ACNE TREATMENT AND METHOD OF ITS APPLICATION | 2016 |
|
RU2614392C1 |
| MEDICAL GEL FOR ERYTHROCYTE AND LEUKOCYTE SEPARATION BY CENTRIFUGATION | 2012 |
|
RU2494788C1 |
| METHOD FOR OBTAINING PLATELET RELEASATE CONTAINING GROWTH FACTORS | 2017 |
|
RU2795884C2 |
| METHOD OF TREATING POST-TRAUMATIC SCARS OF PERI-ORBITAL REGION AND EYELID REGION | 2020 |
|
RU2733576C1 |
| METHOD FOR DIFFERENTIATED TREATMENT OF CORNEAL EROSIONS AND ULCERS | 2021 |
|
RU2765601C1 |
| METHOD OF TREATING DEFECTS OF SKIN AND SOFT TISSUES IN PATIENTS WITH DIABETES MELLITUS AND METHOD OF INTRODUCTION OF DRUG THEREFOR | 2017 |
|
RU2679449C1 |
